Search

Ellen Laber Phones & Addresses

  • 2589 Clearview Ave, Ventura, CA 93001 (805) 644-5216
  • 4745 Loma Vista Rd, Ventura, CA 93003 (805) 644-5216
  • La Jolla, CA
  • 936 3Rd Ave, Redwood City, CA 94063 (650) 261-0456
  • San Francisco, CA
  • San Diego, CA
  • Sacramento, CA
  • Newbury Park, CA

Work

Company: Mineralys therapeutics Jun 2020 Position: Independent consultant medical writing

Education

School / High School: Stanford University 1996 to 1998 Specialities: Organic Chemistry

Skills

Pharmaceutical Industry • Regulatory Submissions • Clinical Development • Drug Discovery • Oncology • Fda • Biotechnology • Clinical Study Reports • Investigational New Drug Applications • Special Protocol Assessments • Regulatory Briefing Packages • Investigator's Brochures • Responses To Questions From Agencies • Medicinal Chemistry • Clinical Research • Regulatory Affairs • Risk Management Plans • Common Technical Document • Manuscript Development • Publication Planning

Ranks

Certificate: Amwa Writing and Editing Certification

Interests

Children • Environment • Education • Science and Technology • Human Rights • Health

Industries

Biotechnology

Resumes

Resumes

Ellen Laber Photo 1

Independent Consultant Medical Writing

View page
Location:
102 Weatherly Cir, Rockwall, TX 75032
Industry:
Biotechnology
Work:
Mineralys Therapeutics
Independent Consultant Medical Writing

Sienna Biopharmaceuticals
Independent Consultant Medical Writing

Allergan Oct 2015 - May 2017
Director Global Medical Writing

Kythera Biopharmaceuticals Sep 2013 - Sep 2015
Director Medical Writing

Egl Medwrite Sep 2010 - Aug 2013
Independent Consultant Medical Writing
Education:
Stanford University 1996 - 1998
Stanford University 1992 - 1997
Uc San Diego 1990 - 1996
Doctorates, Doctor of Philosophy, Organic Chemistry
Duke University 1986 - 1990
Bachelors, Bachelor of Science, Chemistry
Skills:
Pharmaceutical Industry
Regulatory Submissions
Clinical Development
Drug Discovery
Oncology
Fda
Biotechnology
Clinical Study Reports
Investigational New Drug Applications
Special Protocol Assessments
Regulatory Briefing Packages
Investigator's Brochures
Responses To Questions From Agencies
Medicinal Chemistry
Clinical Research
Regulatory Affairs
Risk Management Plans
Common Technical Document
Manuscript Development
Publication Planning
Interests:
Children
Environment
Education
Science and Technology
Human Rights
Health
Certifications:
Amwa Writing and Editing Certification

Publications

Us Patents

Thiazolyl Urea Compounds And Methods Of Uses

View page
US Patent:
7196104, Mar 27, 2007
Filed:
Jul 30, 2003
Appl. No.:
10/631423
Inventors:
Frenel F. De Morin - Thousand Oaks CA, US
Andrew Hague - Camarillo CA, US
Ellen Laber - Ventura CA, US
Aiwen Li - Westlake Village CA, US
Gang Liu - Oak Park CA, US
Patricia Lopez - West Hills CA, US
Rana Nomak - Westlake Village CA, US
Vincent Santora - Carlsbad CA, US
Christopher Tegley - Thousand Oaks CA, US
Kevin Yang - San Gabriel CA, US
Assignee:
Amgen, Inc. - Thousand Oakes CA
International Classification:
A61K 31/44
C07D 417/12
US Classification:
514342, 514370, 5462697
Abstract:
Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Urea Compounds And Methods Of Uses

View page
US Patent:
20020173507, Nov 21, 2002
Filed:
Aug 14, 2001
Appl. No.:
09/930753
Inventors:
Vincent Santora - Thousand Oaks CA, US
Benny Askew - Newbury Park CA, US
Arup Ghose - Thousand Oaks CA, US
Andrew Hague - Camarillo CA, US
Tae Kim - Thousand Oaks CA, US
Ellen Laber - Ventura CA, US
Aiwen Li - Newbury Park CA, US
Brian Lian - Bloomington IN, US
Gang Liu - Oak Park CA, US
Mark Norman - Thousand Oaks CA, US
Leon Smith - Sommerset NJ, US
Andrew Tasker - Simi Valley CA, US
Christopher Tegley - Thousand Oaks CA, US
Kevin Yang - San Gabriel CA, US
International Classification:
A61K031/501
C07D239/02
A61K031/535
A61K031/505
US Classification:
514/227500, 514/237800, 514/241000, 514/242000, 514/247000, 514/252010, 514/256000, 514/252100, 514/252130, 514/315000, 514/326000, 514/649000, 514/432000, 514/459000, 544/059000, 544/162000, 544/180000, 544/182000, 544/224000, 544/238000, 544/242000, 544/333000, 544/359000, 546/229000
Abstract:
Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Thiazolyl Urea Compounds And Methods Of Uses

View page
US Patent:
20020193405, Dec 19, 2002
Filed:
Feb 15, 2002
Appl. No.:
10/077124
Inventors:
Benny Askew - Newbury Park CA, US
Frenel De Morin - Thousand Oaks CA, US
Andrew Hague - Camarillo CA, US
Ellen Laber - Ventura CA, US
Aiwen Li - Westlake Village CA, US
Gang Liu - Oak Park CA, US
Patricia Lopez - Northridge CA, US
Rana Nomak - Westlake Village CA, US
Vincent Santora - Ledera Ranch CA, US
Christopher Tegley - Thousand Oaks CA, US
Kevin Yang - San Gabriel CA, US
International Classification:
A61K031/4545
A61K031/4439
C07D417/14
C07D417/02
US Classification:
514/318000, 514/342000, 546/193000, 546/270700
Abstract:
Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Thiazolyl Urea Compounds And Methods Of Uses

View page
US Patent:
20040044044, Mar 4, 2004
Filed:
Jul 30, 2003
Appl. No.:
10/632044
Inventors:
Benny Askew - Newbury Park CA, US
Frenel De Morin - Thousand Oaks CA, US
Andrew Hague - Camarillo CA, US
Ellen Laber - Ventura CA, US
Aiwen Li - Westlake Village CA, US
Gang Liu - Oak Park CA, US
Patricia Lopez - Northridge CA, US
Rana Nomak - Westlake Village CA, US
Vincent Santora - Ladera Ranch CA, US
Christopher Tegley - Thousand Oaks CA, US
Kevin Yang - San Gabriel CA, US
Assignee:
Amgen Inc.
International Classification:
C07D417/14
C07D417/02
A61K031/4439
A61K031/4545
US Classification:
514/342000, 514/318000, 546/269700, 546/187000
Abstract:
Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Ellen M Laber from Ventura, CA, age ~56 Get Report